Three winners of the long-term biotech boom
Mar 19, 2021
2 minutes
The biotechnology sector has been instrumental in bringing Covid-19 under control. It was not the traditional large pharmaceutical vaccine specialists that led the way, but the innovative biotech firms such as BioNTech and Moderna. These companies have turned a much-discussed idea – vaccines based on RNA, a new approach – into
You’re reading a preview, subscribe to read more.
Start your free 30 days